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Abstract
Atypical appearance of scabies such as
chronic excoriation and eczematization of
the skin, is frequently found in patients with
long-standing infestations. Cases of less
impressive scabies are not easily diagnosed,
especially when topical or systemic corti-
costeroids mask the typical itch and inflam-
mation. These cases frequently occur in
individuals with good hygiene and are
referred as scabies incognito – a diagnosis
that can be easily mistaken for other skin
diseases. A fourteen-year-old male patient
had been irregularly taking systemic corti-
costeroid for two months due to intermittent
papular reaction and itching. Four weeks
after treatment with anti-scabiotic therapy,
the patient has no complaint of itch and no
sign of new papular lesion suggesting that
he had scabies all along. It is very important
to make a correct diagnosis of scabies
incognito because misdiagnosis is associat-
ed with serious consequences such as
spreading and superinfection of the lesions;
this can sometimes lead to life-threatening
consequences. 
Introduction
Scabies is a common parasitic infection
caused by Sarcoptes scabiei. Clinical pres-
entation of its primary infestation
commonly appears four to six weeks after
infection, presented with generalized itch-
ing that gets worse at night. Pruritic papules
are classically found in the webs of the fin-
gers, the flexor of the wrists, the extensor of
the elbows, the periumbilical skin, the but-
tocks, the ankles, the penis in males and the
periareolar region in females. Number of
mites per patient is approximately 10 to 12.1
Depending on the extent and severity of the
inflammatory response, the clinical appear-
ance of scabies varies, but the classical clin-
ical sign for the diagnosis of scabies is the
burrow. Atypical appearance, such as
chronic excoriation and eczematization of
the skin, is frequently found in patients with
longstanding infestations.2 Cases of less
impressive scabies are not easily diagnosed,
especially when topical or systemic corti-
costeroids mask the typical itch and inflam-
mation. These cases frequently occur in
individuals with good hygiene and are
referred as scabies incognito – a diagnosis
that can be easily mistaken for other skin
diseases.3
Case Report
A fourteen-year-old male came with the
chief complaint of moderate itching that
worsened at night. This started eight months
ago. At the first examination with previous
clinician, he was misdiagnosed; his skin
changes were thought to be in relation to an
allergic reaction. He was treated with sys-
temic corticosteroid therapy (dexametha-
sone 0.75mg 3 times a day). During the first
month, the skin changes improved and pru-
ritus became less intensive. Unfortunately,
whenever the dose of corticosteroid was
being tapered, the patient experienced exac-
erbation. Thus, systemic corticosteroid ther-
apy was consumed irregularly for almost
two months.
When he came to our outpatient clinic,
the patient still had complaint of moderate
pruritus that worsened at night. On physical
examination, no papules were seen on his
web of fingers, yet multiple erythematous
papules were found on the penis and scro-
tum (Figure 1). Systemic corticosteroid was
stopped and he was treated with 5% perme-
thrin cream (single dose application, left on
skin for 8 hours). One week later, he came
back with a complaint of persistent and
intensive pruritus. On physical
examination, multiple erythematous
papules appeared in almost all over his
body (Figure 2). Skin scraping was per-
formed from fresh, non-excoriated burrows
on his finger web areas. Direct microscopic
examination identified the mite. The patient
was treated with repeated anti-scabiotic
treatment: 5% permethrin cream, with a
combination of 2% salicylic acid and 4%
precipitated sulphur ointment (for three
consecutive days). This led to a complete
resolution of his skin condition. At the fol-
low-up controls after 2 and 4 weeks, he had
no sign of new lesions.
Discussion
Scabies mites reside in the lower-stra-
tum corneum of epidermis, near the stratum
corneum/stratum lucidum interface.
Intercellular fluid from lower skin zones
leaks into the burrows, providing a medium
for soluble antigens from the mite’s body
and feces to diffuse into the dermis. These
soluble antigens will stimulate an inflam-
matory and immune response. Clinical
symptoms of scabies result from a delayed
host-immune response toward these soluble
antigens.4 Besides alleviating the itching
sensation, steroids can also alleviate local
inflammation, which may camouflage the
progress of skin lesions. This modified
appearance of lesion due to steroids is
known as scabies incognito. Due to variable
presentations of scabies incognito, this
diagnosis can be easily overlooked when
examined with only the naked eye, even by
the experienced dermatologist. Thus,
scabies skin lesions of patients with chronic
usage of steroids should always be
confirmed with microscopic examination.5
Scabies mites have the ability to modu-
late cytokine secretion and the expression
of cell adhesion molecules in skin cells and
other cells of the innate and adaptive
immune systems, all of which are needed by
the mites themselves to survive in the skin.4
Individuals with scabies react to bites by
generating a cell-mediated immune
response at the bite site. This elicits a very
itchy papule that is often excoriated.
Sometimes, ulcerated papules, vasculitis
and nodules develop as a result of other
immunologic reactions in the skin.
Immunologic reactions are mediated by
immunoglobulin IgG, IgM, and especially
                                                     Dermatology Reports 2019; volume 11(s1):8083
Correspondence: Nanny Herwanto,
Dermatology Venereology Dept, Faculty of
Medicine, Universitas Airlangga - DR
Soetomo Teaching Hospital, Jl. Mayjen. Prof.
Dr. Moestopo, No. 47, Airlangga, Gubeng,
Surabaya, Jawa Timur, 60286, Indonesia.
Tel.: +6281333290006.
E-mail: nannyherwanto@gmail.com
Key words: scabies, incognito, corticos-
teroids, misdiagnosis.
Contributions: Conduct: NH, Reporting: NH,
ANH, Editing and Publication: NH,HM, SW,
TI, S, EE, DM, SM.
Conflict of interest: Dr. Herwanto has nothing
to disclose.
Received for publication: 1 February 2019.
Accepted for publication: 22 February 2019.
This work is licensed under a Creative
Commons Attribution-NonCommercial 4.0
International License (CC BY-NC 4.0).
©Copyright N. Herwanto et al., 2019
Licensee PAGEPress, Italy
Dermatology Reports 2019; 11(s1):8083
doi:10.4081/dr.2019.8083
No
n-c
om
me
rci
l u
s
 o
ly
[page 158]                                                    [Dermatology Reports 2019; 11(s1):8083]
IgE classes. None of these reactions has
been shown to eliminate all mites from the
skin surface, yet may prevent local epider-
mic multiplication of scabies mites on the
skin surface.6
Cytokine IL-10 increases significantly
in individuals with scabies. This cytokine is
able to inhibit the synthesis of the proin-
flammatory cytokines IFN-γ, IL-2 and TNF
and to stimulate certain T-cells’, mast cells’,
and B-cells’ maturation and antibody
production. These results suggest that IL-10
may play a role in the human delayed-
immune response by depressing the inflam-
matory and allergic responses, so that clini-
cal symptoms are not seen until four to six
weeks after a person becomes infested with
scabies mites.7
Topical or systemic corticosteroids alter
the skin’s immune system by reducing the
inflammatory response and suppressing
cell-mediated immunity in the skin.8 It has
been postulated that immunosuppressant
therapy may inhibit the primary immune
response.9 Cortisol decreases macrophage
functions - such as phagocytosing, antigen
processing and cell killing - and affects
immediate and delayed hypersensitivity.
Glucocorticoids impair delayed-type hyper-
sensitivity reactions because of their ability
to inhibit lymphocytes and monocytes. The
patient had been irregularly taking systemic
corticosteroid (dexamethasone 0.75mg
three times a day) for two months due to
intermittent papular reaction and itching.
Four weeks after treatment with anti-scabi-
otic therapy, the patient has no complaint of
itching and no sign of new papular lesions
—suggesting that he had scabies all along.
Conclusions
It is very important to make a correct
diagnosis of scabies incognito because mis-
diagnosis is associated with serious conse-
quences such as the spreading of the infes-
tation and superinfection of the lesions.
These can, in turn, lead to life-threatening
consequences.10
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Figure 1. Multiple erythematous papules were found on his penis and scrotum. No papules on the webs of his fingers.
Figure 2. One week after the first treatment and stopping the systemic corticosteroid, multiple erythematous papules appeared in
almost all over his body.
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